Abstract
Health-related quality of life and treatment burden in patients with proliferative lupus nephritis treated with cyclophosphamide or azathioprine/ methylprednisolone in a randomized controlled trial.
Cecile Grootscholten, Frank J Snoek, Marc Bijl, Hans C van Houwelingen, Ronald H W M Derksen, Jo H M Berden and Dutch Working Party of SLE
The Journal of Rheumatology August 2007, 34 (8) 1699-1707;
Cecile Grootscholten
Frank J Snoek
Marc Bijl
Hans C van Houwelingen
Ronald H W M Derksen
In this issue
The Journal of Rheumatology
Vol. 34, Issue 8
1 Aug 2007
Health-related quality of life and treatment burden in patients with proliferative lupus nephritis treated with cyclophosphamide or azathioprine/ methylprednisolone in a randomized controlled trial.
Cecile Grootscholten, Frank J Snoek, Marc Bijl, Hans C van Houwelingen, Ronald H W M Derksen, Jo H M Berden, Dutch Working Party of SLE
The Journal of Rheumatology Aug 2007, 34 (8) 1699-1707;
Health-related quality of life and treatment burden in patients with proliferative lupus nephritis treated with cyclophosphamide or azathioprine/ methylprednisolone in a randomized controlled trial.
Cecile Grootscholten, Frank J Snoek, Marc Bijl, Hans C van Houwelingen, Ronald H W M Derksen, Jo H M Berden, Dutch Working Party of SLE
The Journal of Rheumatology Aug 2007, 34 (8) 1699-1707;